CLIA lab

CLIA 05D1096670: Anchor Drugs III

South San Francisco, CA. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 05D1096670 belongs to Anchor Drugs III in South San Francisco, CA.

Certificate of Waiver, effective March 10, 2025, expires March 9, 2027.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
March 10, 2025
Certificate expiration
March 9, 2027
Status in the CMS file
Active (termination code 00)
Original participation date
March 10, 2009
Facility type
Pharmacy
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
05D1096670
Lab name
Anchor Drugs III
Address
161 S Spruce Ave, South San Francisco, CA 94080
Phone
(650) 360-5300
Fax
(650) 360-5325

Annual test volume the lab reported

Waived tests
250

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in South San Francisco, CA

Related

Questions

What is the CLIA number for Anchor Drugs III in South San Francisco?

05D1096670, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Anchor Drugs III hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 05D1096670 expire?

The CMS file lists March 9, 2027 as the certificate expiration date; the certificate took effect March 10, 2025.

Try it on your own data today.

Free to start. Most teams are using it the same day.